| Literature DB >> 26819209 |
Takashi Yoshida1, Hidefumi Kinoshita2, Kenji Yoshida1, Takao Mishima1, Masaaki Yanishi1, Hidekazu Inui1, Yoshihiro Komai1, Motohiko Sugi1, Takaaki Inoue3, Takashi Murota3, Katsuya Fukui4, Jiro Harada5, Gen Kawa5, Tadashi Matsuda1.
Abstract
Various systemic inflammatory response biomarkers are associated with oncological outcome. We evaluated the superiority of prognostic predictive accuracy between neutrophil-lymphocyte ratio (NLR) and lymphocyte-monocyte ratio (LMR), and the prognostic significance of their perioperative change in patients with bladder cancer undergoing radical cystectomy (RC). We retrospectively analyzed 302 patients who had undergone RC in four institutions. Comparison of predictive accuracy between NLR and LMR was performed using receiver operating characteristic curve analysis. Overall survival (OS) and cancer-specific survival (CSS) were assessed with the Kaplan-Meier method and Cox regression analysis. Preoperative and postoperative LMR showed higher predictive accuracy for OS than NLR did (p = 0.034). Applying a cutoff of 3.41, change in perioperative LMR stratified patients into three groups (low, intermediate, and high risk), showing a significant difference in OS and CSS (p < 0.001, each), and pathological outcomes. Multivariable analyses for OS and CSS showed that poor changes in LMR (high risk) were an independent prognostic factor (hazard ratio 5.70, 95 % confidence interval 3.49-9.32, p < 0.001; hazard ratio 4.53, 95 % confidence interval 2.63-7.82, p < 0.001; respectively). Perioperative LMR is significantly associated with survival in patients with bladder cancer after RC, and it is possibly superior to NLR as a prognostic factor.Entities:
Keywords: Bladder cancer; Lymphocyte–monocyte ratio; Neutrophil–lymphocyte ratio; Perioperative change; Prognosis; Radical cystectomy
Mesh:
Substances:
Year: 2016 PMID: 26819209 DOI: 10.1007/s13277-016-4874-8
Source DB: PubMed Journal: Tumour Biol ISSN: 1010-4283